通过情景案例和优先级评分探索风湿科医生对中轴型脊柱关节炎缓解概念的认识
该横断面调查于2020年纳入200名法国风湿科医生,使用36个情景案例和12项优先级排序评估对中轴型脊柱关节炎(axSpA)缓解的认知。2400次案例评估中19%被判定为缓解,晨僵<15分钟且轴向疼痛≤3/10的6个案例占所有缓解案例的56%,疲劳与缓解关联较弱;优先考虑的项目包括晨僵、关节外表现、NSAID使用、轴向疼痛和CRP。
要点
- 晨僵<15分钟且轴向疼痛≤3/10是医生判定缓解的主要情景特征。
- 疲劳在缓解概念中权重较低,关节外表现和NSAID使用被纳入考量。
- axSpA缓解定义尚缺乏共识,需进一步统一。
核心结论
- 风湿科医生在概念化axSpA缓解时主要考虑晨僵和轴向疼痛,疲劳与缓解的关联较弱,同时纳入关节外表现和NSAID使用。
- axSpA缓解定义仍需达成共识。
研究设计与样本
- 2020年对法国风湿科医生进行的横断面调查,使用36个情景案例(单一临床画面,轴向疼痛2-5/10、疲劳2-8、晨僵<15分钟/30分钟/1小时三个可变参数)评估是否缓解,并对12项缓解考虑要素进行优先级排序。
- 共200名法国风湿科医生参与,完成2400次情景案例评估。
主要发现
- 2400次情景案例评估中463次(19%)被分类为缓解。
- 占所有缓解案例56%的6个情景案例均具有晨僵持续时间<15分钟和轴向疼痛≤3/10,且与疲劳水平无关。
- 缓解优先级排序中,晨僵(75%)、关节外表现(75%)、NSAID使用(71%)、轴向疼痛(68%)和CRP(66%)被优先考虑。
关键数值与推荐
- 缓解判定情景特征:晨僵<15分钟且轴向疼痛≤3/10,无论疲劳水平。
- 优先级排序前五位:晨僵75%、关节外表现75%、NSAID使用71%、轴向疼痛68%、CRP 66%。
临床怎么用
- 临床评估axSpA缓解时可关注晨僵持续时间<15分钟和轴向疼痛≤3/10,并综合考虑关节外表现和NSAID使用。
- 疲劳在缓解判定中权重较低,但仍需结合患者整体情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The optimal treatment target in axial spondyloarthritis (axSpA) is remission; however, a consensual definition of remission is lacking. Our objective was to explore rheumatologists' perception of remission using vignette cases and a priority exercise. METHODS: A cross-sectional survey of rheumatologists' perceptions of remission in axSpA was performed in 2020 using (i) 36 vignette cases, with a single clinical picture and three varying parameters [axial pain (ranging from 2 to 5 on a 0-10 scale)], fatigue (2-8), and morning stiffness (<15 min, 30 min or 1 h), assessed as remission yes/no; and (ii) prioritization of elements to consider for remission from a list of 12 items: BASDAI, ASDAS, elements of BASDAI and ASDAS including CRP, NSAID use, extra-articular manifestations (EAMs), and other explanations of symptoms, e.g. fibromyalgia. Analyses were descriptive. RESULTS: Overall, 200 French rheumatologists participated in 2400 vignette evaluations. Of these, 463 (19%) were classified as remission. The six vignette cases representing 56% of all remission cases had <15 min duration of morning stiffness and axial pain ≤3/10, regardless of fatigue levels. Prioritized items for remission were: morning stiffness (75%), EAMs (75%), NSAID use (71%), axial pain (68%) and CRP (66%). CONCLUSIONS: When conceptualizing remission in axSpA, rheumatologists took into account morning stiffness and axial pain as expected; the link between remission and fatigue was much weaker. Furthermore, rheumatologists also included EAMs and NSAID use in the concept of remission. Consensus is needed for definition of remission in axSpA.
引用
- Aouad K, Wendling D, Breban M, et al. Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings. Rheumatology (Oxford). 2022. PMID: 34528070. doi:10.1093/rheumatology/keab711
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。